Clinical Trial Update: A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating response-guided therapy with pegylated interferon alfa plus ribavirin in patients with hepatitis B and hepatitis C co-infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C

Drugs mentioned

• Peginterferon alfa (pegylated interferon alpha)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: HBV/HCV Co-infection | Phase 4 | Status: COMPLETED